Vitamin D Deficiency and Chronic Obstructive Pulmonary Disease. A Vicious Circle.

Vitamins and Hormones

Volumn 86, Issue , 2011, Pages 379-399

  Janssens, Wim ^a   Mathieu, Chantal ^a   Boonen, Steven ^a   Decramer, Marc ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Bone; COPD; Inflammation; Muscle; Osteoporosis; Systemic effects; Vitamin D

Indexed keywords

VITAMIN D;

ANIMAL; BOOK; CALCIUM INTAKE; CHRONIC OBSTRUCTIVE LUNG DISEASE; DIET SUPPLEMENTATION; DIET THERAPY; HUMAN; OSTEOPOROSIS; PATHOPHYSIOLOGY; VITAMIN D DEFICIENCY;

ANIMALS; CALCIUM, DIETARY; DIETARY SUPPLEMENTS; HUMANS; OSTEOPOROSIS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 79952671210     PISSN: 00836729     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-386960-9.00017-4     Document Type: Book

References (112)

1. Agusti A.G. Systemic effects of chronic obstructive pulmonary disease. Proc. Am. Thorac. Soc. 2005, 2:367-370.
2. Avenell A., Gillespie W.J., Gillespie L.D., O'l D. Vitamin D and vitamin D analogues for preventing fractures associated with involutional and post-menopausal osteoporosis. Cochrane Database Syst. Rev. 2009, 2.
3. Baeke F., van Etten E., Gysemans C., Overbergh L., Mathieu C. Vitamin D signaling in immune-mediated disorders: Evolving insights and therapeutic opportunities. Mol. Aspects Med. 2008, 29:376-387.
4. Baldock P.A., Thomas G.P., Hodge J.M., Baker S.U., Dressel U., O'Loughlin P.D., Nicholson G.C., Briffa K.H., Eisman J.A., Gardiner E.M. Vitamin D action and regulation of bone remodeling: Suppression of osteoclastogenesis by the mature osteoblast. J. Bone Miner. Res. 2006, 21:1618-1626.
5. Bals R., Wang X., Zasloff M., Wilson J.M. The peptide antibiotic LL-37/hCAP-18 is expressed in epithelia of the human lung where it has broad antimicrobial activity at the airway surface. Proc. Natl. Acad. Sci. USA 1998, 95:9541-9546.
6. Barnes P.J. Chronic obstructive pulmonary disease. N. Engl. J. Med. 2000, 343:269-280.
7. Barnes P.J. Immunology of asthma and chronic obstructive pulmonary disease. Nat. Rev. Immunol. 2008, 8:183-192.
8. Barrat F.J., Cua D.J., Boonstra A., Richards D.F., Crain C., Savelkoul H.F., de Waal-Malefyt R., Coffman R.L., Hawrylowicz C.M., O'Garra A. In vitro generation of interleukin 10-producing regulatory CD4(+) T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines. J. Exp. Med. 2002, 195:603-616.
9. Barrett-Connor E., Nielson C.M., Orwoll E., Bauer D.C., Cauley J.A. Epidemiology of rib fractures in older men: Osteoporotic Fractures in Men (MrOS) prospective cohort study. BMJ 2010, 340:c1069.
10. Bischoff-Ferrari H.A., Dietrich T., Orav E.J., Hu F.B., Zhang Y., Karlson E.W., wson-Hughes B. Higher 25-hydroxyvitamin D concentrations are associated with better lower-extremity function in both active and inactive persons aged > or =60 y. Am. J. Clin. Nutr. 2004, 80:752-758.
11. Bischoff-Ferrari H.A., wson-Hughes B., Willett W.C., Staehelin H.B., Bazemore M.G., Zee R.Y., Wong J.B. Effect of vitamin D on falls: A meta-analysis. JAMA 2004, 291:1999-2006.
12. Bischoff-Ferrari H.A., Giovannucci E., Willett W.C., Dietrich T., wson-Hughes B. Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am. J. Clin. Nutr. 2006, 84:18-28.
13. Black P.N., Scragg R. Relationship between serum 25-hydroxyvitamin d and pulmonary function in the third national health and nutrition examination survey. Chest 2005, 128:3792-3798.
14. Boonen S., Lips P., Bouillon R., Bischoff-Ferrari H.A., Vanderschueren D., Haentjens P. Need for additional calcium to reduce the risk of hip fracture with vitamin d supplementation: Evidence from a comparative metaanalysis of randomized controlled trials. J. Clin. Endocrinol. Metab. 2007, 92:1415-1423.
15. Bouillon R., Bischoff-Ferrari H., Willett W. Vitamin D and health: Perspectives from mice and man. J. Bone Miner. Res. 2008, 23:974-979.
16. Bouillon R., Carmeliet G., Verlinden L., van Etten E., Verstuyf A., Luderer H.F., Lieben L., Mathieu C., Demay M. Vitamin D and human health: Lessons from vitamin D receptor null mice. Endocr. Rev. 2008, 29:726-776.
17. Brehm J.M., Celedon J.C., Soto-Quiros M.E., Avila L., Hunninghake G.M., Forno E., Laskey D., Sylvia J.S., Hollis B.W., Weiss S.T., Litonjua A.A. Serum vitamin D levels and markers of severity of childhood asthma in Costa Rica. Am. J. Respir. Crit. Care Med. 2009, 179:765-771.
18. Brusselle G.G., Demoor T., Bracke K.R., Brandsma C.A., Timens W. Lymphoid follicles in (very) severe COPD: Beneficial or harmful?. Eur. Respir. J. 2009, 34:219-230.
19. Calverley P.M., Anderson J.A., Celli B., Ferguson G.T., Jenkins C., Jones P.W., Yates J.C., Vestbo J. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N. Engl. J. Med. 2007, 356:775-789.
20. Cannell J.J., Vieth R., Umhau J.C., Holick M.F., Grant W.B., Madronich S., Garland C.F., Giovannucci E. Epidemic influenza and vitamin D. Epidemiol. Infect. 2006, 134:1129-1140.
21. Chapuy M.C., Preziosi P., Maamer M., Arnaud S., Galan P., Hercberg S., Meunier P.J. Prevalence of vitamin D insufficiency in an adult normal population. Osteoporos. Int. 1997, 7:439-443.
22. Chishimba L., Thickett D.R., Stockley R.A., Wood A.M. The vitamin D axis in the lung: A key role for vitamin D-binding protein. Thorax 2010, 65:456-462.
23. Chiu K.C., Chu A., Go V.L., Saad M.F. Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction. Am. J. Clin. Nutr. 2004, 79:820-825.
24. Cosio B.G., Agusti A. Update in chronic obstructive pulmonary disease 2009. Am. J. Respir. Crit. Care Med. 2010, 181:655-660.
25. Cosio M.G., Majo J., Cosio M.G. Inflammation of the airways and lung parenchyma in COPD: Role of T cell. Chest 2002, 121:160S-165S.
26. Cosio M.G., Saetta M., Agusti A. Immunologic aspects of chronic obstructive pulmonary disease. N. Engl. J. Med. 2009, 360:2445-2454.
27. Daniel C., Sartory N.A., Zahn N., Radeke H.H., Stein J.M. Immune modulatory treatment of trinitrobenzene sulfonic acid colitis with calcitriol is associated with a change of a T helper (Th) 1/Th17 to a Th2 and regulatory T cell profile. J. Pharmacol. Exp. Ther. 2008, 324:23-33.
28. Dawson-Hughes B., Harris S.S., Krall E.A., Dallal G.E. Effect of withdrawal of calcium and vitamin D supplements on bone mass in elderly men and women. Am. J. Clin. Nutr. 2000, 72:745-750.
29. Dawson-Hughes B., Heaney R.P., Holick M.F., Lips P., Meunier P.J., Vieth R. Estimates of optimal vitamin D status. Osteoporos. Int. 2005, 16:713-716.
30. Decramer M., de Bock V., Dom R. Functional and histologic picture of steroid-induced myopathy in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 1996, 153:1958-1964.
31. Decramer M., Gosselink R., Troosters T., Verschueren M., Evers G. Muscle weakness is related to utilization of health care resources in COPD patients. Eur. Respir. J. 1997, 10:417-423.
32. Decramer M., Gosselink R., Troosters T., Schepers R. Peripheral muscle force is a determinant of survival in COPD. Eur. Respir. J. 1998, 12:261S. Abstract.
33. Decramer M., De B.F., Del P.A., Marinari S. Systemic effects of COPD. Respir. Med. 2005, 99(Suppl. B):S3-S10.
34. Decramer M., Rennard S., Troosters T., Mapel D.W., Giardino N., Mannino D., Wouters E., Sethi S., Cooper C.B. COPD as a lung disease with systemic consequences-Clinical impact, mechanisms, and potential for early intervention. COPD 2008, 5:235-256.
35. DeLuca H.F. Overview of general physiologic features and functions of vitamin D. Am. J. Clin. Nutr. 2004, 80:1689S-1696S.
36. Dimeloe S., Nanzer A., Ryanna K., Hawrylowicz C. Regulatory T cells, inflammation and the allergic response-The role of glucocorticoids and vitamin D. J. Steroid Biochem. Mol. Biol. 2010, 120:86-95.
37. Donaldson G.C., Seemungal T.A., Bhowmik A., Wedzicha J.A. Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax 2002, 57:847-852.
38. Fabbri L.M., Rabe K.F. From COPD to chronic systemic inflammatory syndrome?. Lancet 2007, 370:797-799.
39. Forli L., Halse J., Haug E., Bjortuft O., Vatn M., Kofstad J., Boe J. Vitamin D deficiency, bone mineral density and weight in patients with advanced pulmonary disease. J. Intern. Med. 2004, 256:56-62.
40. Forman J.P., Giovannucci E., Holmes M.D., Bischoff-Ferrari H.A., Tworoger S.S., Willett W.C., Curhan G.C. Plasma 25-hydroxyvitamin D levels and risk of incident hypertension. Hypertension 2007, 49:1063-1069.
41. Franco C.B., Paz-Filho G., Gomes P.E., Nascimento V.B., Kulak C.A., Boguszewski C.L., Borba V.Z. Chronic obstructive pulmonary disease is associated with osteoporosis and low levels of vitamin D. Osteoporos. Int. 2009, 20:1881-1887.
42. Fu L., Yun F., Oczak M., Wong B.Y., Vieth R., Cole D.E. Common genetic variants of the vitamin D binding protein (DBP) predict differences in response of serum 25-hydroxyvitamin D [25(OH)D] to vitamin D supplementation. Clin. Biochem. 2009, 42:1174-1177.
43. Ginde A.A., Mansbach J.M., Camargo C.A. Association between serum 25-hydroxyvitamin D level and upper respiratory tract infection in the Third National Health and Nutrition Examination Survey. Arch. Intern. Med. 2009, 169:384-390.
44. Ginde A.A., Scragg R., Schwartz R.S., Camargo C.A. Prospective study of serum 25-hydroxyvitamin D level, cardiovascular disease mortality, and all-cause mortality in older U.S. adults. J. Am. Geriatr. Soc. 2009, 57:1595-1603.
45. Giovannucci E., Liu Y., Rimm E.B., Hollis B.W., Fuchs C.S., Stampfer M.J., Willett W.C. Prospective study of predictors of vitamin D status and cancer incidence and mortality in men. J. Natl. Cancer Inst. 2006, 98:451-459.
46. Gosselink R., Troosters T., Decramer M. Peripheral muscle weakness contributes to exercise limitation in COPD. Am. J. Respir. Crit. Care Med. 1996, 153:976-980.
47. Graat-Verboom L., van den Borne B.E., Smeenk F.W., Spruit M.A., Wouters E.F. Osteoporosis in COPD outpatients based on bone mineral density and vertebral fractures. J. Bone. Miner. Res. 2010, 27. Epub.
48. Graat-Verboom L., Wouters E.F., Smeenk F.W., van den Borne B.E., Lunde R., Spruit M.A. Current status of research on osteoporosis in COPD: A systematic review. Eur. Respir. J. 2009, 34:209-218.
49. Haentjens P., Magaziner J., Colon-Emeric C.S., Vanderschueren D., Milisen K., Velkeniers B., Boonen S. Meta-analysis: Excess mortality after hip fracture among older women and men. Ann. Intern. Med. 2010, 152:380-390.
50. Hamilton B. Vitamin D and human skeletal muscle. Scand. J. Med. Sci. Sports 2010, 20:182-190.
51. Hanak V., Hartman T.E., Ryu J.H. Cough-induced rib fractures. Mayo Clin. Proc. 2005, 80:879-882.
52. Hogg J.C., Chu F., Utokaparch S., Woods R., Elliott W.M., Buzatu L., Cherniack R.M., Rogers R.M., Sciurba F.C., Coxson H.O., Pare P.D. The nature of small-airway obstruction in chronic obstructive pulmonary disease. N. Engl. J. Med. 2004, 350:2645-2653.
53. Holick M.F. Vitamin D deficiency. N. Engl. J. Med. 2007, 357:266-281.
54. Hopkinson N.S., Li K.W., Kehoe A., Humphries S.E., Roughton M., Moxham J., Montgomery H., Polkey M.I. Vitamin D receptor genotypes influence quadriceps strength in chronic obstructive pulmonary disease. Am. J. Clin. Nutr. 2008, 87:385-390.
55. Janssens W., Bouillon R., Claes B., Carremans C., Lehouck A., Buysschaert I., Coolen J., Mathieu C., Decramer M., Lambrechts D. Vitamin D deficiency is highly prevalent in COPD and correlates with variants in the vitamin D binding gene. Thorax 2009, 65:215-220.
56. Janssens W., Lehouck A., Carremans C., Bouillon R., Mathieu C., Decramer M. Vitamin D beyond bones in chronic obstructive pulmonary disease: Time to act. Am. J. Respir. Crit. Care Med. 2009, 179:630-636.
57. Kanis J.A. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: Synopsis of a WHO report. WHO Study Group. Osteoporos. Int. 1994, 4:368-381.
58. Kanis J.A. Diagnosis of osteoporosis and assessment of fracture risk. Lancet 2002, 359:1929-1936.
59. Kanis J.A., Johansson H., Oden A., Johnell O., de Laet C., Melton L.J., Tenenhouse A., Reeve J., Silman A.J., Pols H.A., Eisman J.A., McCloskey E.V., et al. A meta-analysis of prior corticosteroid use and fracture risk. J. Bone Miner. Res. 2004, 19:893-899.
60. Kanis J.A., Johnell O., Oden A., Johansson H., McCloskey E. FRAX and the assessment of fracture probability in men and women from the UK. Osteoporos. Int. 2008, 19:385-397.
61. Kjensli A., Mowinckel P., Ryg M.S., Falch J.A. Low bone mineral density is related to severity of chronic obstructive pulmonary disease. Bone 2007, 40:493-497.
62. Lacey D.L., Timms E., Tan H.L., Kelley M.J., Dunstan C.R., Burgess T., Elliott R., Colombero A., Elliott G., Scully S., Hsu H., Sullivan J., et al. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 1998, 93:165-176.
63. Lappe J.M., Travers-Gustafson D., Davies K.M., Recker R.R., Heaney R.P. Vitamin D and calcium supplementation reduces cancer risk: Results of a randomized trial. Am. J. Clin. Nutr. 2007, 85:1586-1591.
64. Lauridsen A.L., Vestergaard P., Hermann A.P., Brot C., Heickendorff L., Mosekilde L., Nexo E. Plasma concentrations of 25-hydroxy-vitamin D and 1, 25-dihydroxy-vitamin D are related to the phenotype of Gc (vitamin D-binding protein): A cross-sectional study on 595 early postmenopausal women. Calcif. Tissue Int. 2005, 77:15-22.
65. Lee S.H., Goswami S., Grudo A., Song L.Z., Bandi V., Goodnight-White S., Green L., Hacken-Bitar J., Huh J., Bakaeen F., Coxson H.O., Cogswell S., et al. Antielastin autoimmunity in tobacco smoking-induced emphysema. Nat. Med. 2007, 13:567-569.
66. Lee J.H., O'Keefe J.H., Bell D., Hensrud D.D., Holick M.F. Vitamin D deficiency an important, common, and easily treatable cardiovascular risk factor?. J. Am. Coll. Cardiol. 2008, 52:1949-1956.
67. Leech J.A., Dulberg C., Kellie S., Pattee L., Gay J. Relationship of lung function to severity of osteoporosis in women. Am. Rev. Respir. Dis. 1990, 141:68-71.
68. Leibbrandt A., Penninger J.M. RANK/RANKL: Regulators of immune responses and bone physiology. Ann. NY Acad. Sci. 2008, 1143:123-150.
69. Lips P. Vitamin D deficiency and secondary hyperparathyroidism in the elderly: Consequences for bone loss and fractures and therapeutic implications. Endocr. Rev. 2001, 22:477-501.
70. Lips P. Vitamin D physiology. Prog. Biophys. Mol. Biol. 2006, 92:4-8.
71. Liu P.T., Stenger S., Li H., Wenzel L., Tan B.H., Krutzik S.R., Ochoa M.T., Schauber J., Wu K., Meinken C., Kamen D.L., Wagner M., et al. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 2006, 311:1770-1773.
72. Lyles K.W., Gold D.T., Shipp K.M., Pieper C.F., Martinez S., Mulhausen P.L. Association of osteoporotic vertebral compression fractures with impaired functional status. Am. J. Med. 1993, 94:595-601.
73. Manolagas S.C., Jilka R.L. Bone marrow, cytokines, and bone remodeling. Emerging insights into the pathophysiology of osteoporosis. N. Engl. J. Med. 1995, 332:305-311.
74. Mathers C.D., Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med. 2006, 3:e442.
75. Mathieu C., Adorini L. The coming of age of 1, 25-dihydroxyvitamin D(3) analogs as immunomodulatory agents. Trends Mol. Med. 2002, 8:174-179.
76. Mathieu C., Waer M., Laureys J., Rutgeerts O., Bouillon R. Prevention of autoimmune diabetes in NOD mice by 1, 25 dihydroxyvitamin D. Diabetologia 1994, 37:552-558.
77. Matsuo K. Cross-talk among bone cells. Curr. Opin. Nephrol. Hypertens. 2009, 18:292-297.
78. Merlino L.A., Curtis J., Mikuls T.R., Cerhan J.R., Criswell L.A., Saag K.G. Vitamin D intake is inversely associated with rheumatoid arthritis: Results from the Iowa Women's Health Study. Arthritis Rheum. 2004, 50:72-77.
79. Molfino N.A., Coyle A.J. Gene-environment interactions in chronic obstructive pulmonary disease. Int. J. Chron. Obstruct. Pulmon. Dis. 2008, 3:491-497.
80. Munger K.L., Levin L.I., Hollis B.W., Howard N.S., Ascherio A. Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. JAMA 2006, 296:2832-2838.
81. Nevitt M.C., Ettinger B., Black D.M., Stone K., Jamal S.A., Ensrud K., Segal M., Genant H.K., Cummings S.R. The association of radiographically detected vertebral fractures with back pain and function: A prospective study. Ann. Intern. Med. 1998, 128:793-800.
82. Niewoehner D.E. The impact of severe exacerbations on quality of life and the clinical course of chronic obstructive pulmonary disease. Am. J. Med. 2006, 119:38-45.
83. Nnoaham K.E., Clarke A. Low serum vitamin D levels and tuberculosis: A systematic review and meta-analysis. Int. J. Epidemiol. 2008, 37:113-119.
84. Norman A.W., Bouillon R., Whiting S.J., Vieth R., Lips P. 13th Workshop consensus for vitamin D nutritional guidelines. J. Steroid Biochem. Mol. Biol. 2007, 103:204-205.
85. Nuti R., Siviero P., Maggi S., Guglielmi G., Caffarelli C., Crepaldi G., Gonnelli S. Vertebral fractures in patients with chronic obstructive pulmonary disease: The EOLO Study. Osteoporos. Int. 2009, 20:989-998.
86. Overbergh L., Decallonne B., Valckx D., Verstuyf A., Depovere J., Laureys J., Rutgeerts O., Saint-Arnaud R., Bouillon R., Mathieu C. Identification and immune regulation of 25-hydroxyvitamin D-1-alpha-hydroxylase in murine macrophages73. Clin. Exp. Immunol. 2000, 120:139-146.
87. Papaioannou A., Kennedy C.C., Cranney A., Hawker G., Brown J.P., Kaiser S.M., Leslie W.D., O'Brien C.J., Sawka A.M., Khan A., Siminoski K., Tarulli G., et al. Risk factors for low BMD in healthy men age 50 years or older: A systematic review. Osteoporos. Int. 2009, 20:507-518.
88. Patel M.S., Karsenty G. Regulation of bone formation and vision by LRP5. N. Engl. J. Med. 2002, 346:1572-1574.
89. Rabe K.F., Hurd S., Anzueto A., Barnes P.J., Buist S.A., Calverley P., Fukuchi Y., Jenkins C., Rodriguez-Roisin R., van Weel C., Zielinski J. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am. J. Respir. Crit. Care Med. 2007, 176:532-555.
90. Raisz L.G. Pathogenesis of osteoporosis: Concepts, conflicts, and prospects. J. Clin. Invest. 2005, 115:3318-3325.
91. Sadeghi K., Wessner B., Laggner U., Ploder M., Tamandl D., Friedl J., Zugel U., Steinmeyer A., Pollak A., Roth E., Boltz-Nitulescu G., Spittler A. Vitamin D3 down-regulates monocyte TLR expression and triggers hyporesponsiveness to pathogen-associated molecular patterns. Eur. J. Immunol. 2006, 36:361-370.
92. Sambrook P., Cooper C. Osteoporosis. Lancet 2006, 367:2010-2018.
93. Schurch M.A., Rizzoli R., Mermillod B., Vasey H., Michel J.P., Bonjour J.P. A prospective study on socioeconomic aspects of fracture of the proximal femur. J. Bone Miner. Res. 1996, 11:1935-1942.
94. Scragg R., Sowers M., Bell C. Serum 25-hydroxyvitamin D, diabetes, and ethnicity in the Third National Health and Nutrition Examination Survey. Diab. Care 2004, 27:2813-2818.
95. Sethi S., Mallia P., Johnston S.L. New paradigms in the pathogenesis of chronic obstructive pulmonary disease II. Proc. Am. Thorac. Soc. 2009, 6:532-534.
96. Sin D.D., Man J.P., Man S.F. The risk of osteoporosis in Caucasian men and women with obstructive airways disease. Am. J. Med. 2003, 114:10-14.
97. Sinotte M., Diorio C., Berube S., Pollak M., Brisson J. Genetic polymorphisms of the vitamin D binding protein and plasma concentrations of 25-hydroxyvitamin D in premenopausal women. Am. J. Clin. Nutr. 2009, 89:634-640.
98. Speeckaert M., Huang G., Delanghe J.R., Taes Y.E. Biological and clinical aspects of the vitamin D binding protein (Gc-globulin) and its polymorphism. Clin. Chim. Acta 2006, 372:33-42.
99. Suda T., Takahashi N., Udagawa N., Jimi E., Gillespie M.T., Martin T.J. Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families. Endocr. Rev. 1999, 20:345-357.
100. Sutherland E.R., Goleva E., Jackson L.P., Stevens A.D., Leung D.Y. Vitamin D levels, lung function, and steroid response in adult asthma. Am. J. Respir. Crit. Care Med. 2010, 181:699-704.
101. Uitterlinden A.G., Fang Y., Van Meurs J.B., Pols H.A., Van Leeuwen J.P. Genetics and biology of vitamin D receptor polymorphisms. Gene 2004, 338:143-156.
102. van Etten E., Mathieu C. Immunoregulation by 1, 25-dihydroxyvitamin D3: Basic concepts. J. Steroid Biochem. Mol. Biol. 2005, 97:93-101.
103. van Staa T.P., Leufkens H.G., Cooper C. The epidemiology of corticosteroid-induced osteoporosis: A meta-analysis. Osteoporos. Int. 2002, 13:777-787.
104. Vieth R. Vitamin D toxicity, policy, and science. J. Bone Miner. Res. 2007, 22(Suppl. 2):V64-V68.
105. Vrieze A., de Greef M.H., Wijkstra P.J., Wempe J.B. Low bone mineral density in COPD patients related to worse lung function, low weight and decreased fat-free mass. Osteoporos. Int. 2007, 18:1197-1202.
106. Wang T.T., Nestel F.P., Bourdeau V., Nagai Y., Wang Q., Liao J., Tavera-Mendoza L., Lin R., Hanrahan J.W., Mader S., White J.H. Cutting edge: 1, 25-Dihydroxyvitamin D3 is a direct inducer of antimicrobial peptide gene expression. J. Immunol. 2004, 173:2909-2912.
107. Wang T.J., Pencina M.J., Booth S.L., Jacques P.F., Ingelsson E., Lanier K., Benjamin E.J., D'Agostino R.B., Wolf M., Vasan R.S. Vitamin D deficiency and risk of cardiovascular disease. Circulation 2008, 117:503-511.
108. Wicherts I.S., van Schoor N.M., Boeke A.J., Visser M., Deeg D.J., Smit J., Knol D.L., Lips P. Vitamin D status predicts physical performance and its decline in older persons. J. Clin. Endocrinol. Metab. 2007, 92:2058-2065.
109. Wright R.J. Make no bones about it: Increasing epidemiologic evidence links vitamin D to pulmonary function and COPD. Chest 2005, 128:3781-3783.
110. Xystrakis E., Kusumakar S., Boswell S., Peek E., Urry Z., Richards D.F., Adikibi T., Pridgeon C., Dallman M., Loke T.K., Robinson D.S., Barrat F.J., et al. Reversing the defective induction of IL-10-secreting regulatory T cells in glucocorticoid-resistant asthma patients. J. Clin. Invest. 2006, 116:146-155.
111. Zhou W., Heist R.S., Liu G., Neuberg D.S., Asomaning K., Su L., Wain J.C., Lynch T.J., Giovannucci E., Christiani D.C. Polymorphisms of vitamin D receptor and survival in early-stage non-small cell lung cancer patients. Cancer Epidemiol. Biomarkers Prev. 2006, 15:2239-2245.
112. Zhou W., Heist R.S., Liu G., Asomaning K., Neuberg D.S., Hollis B.W., Wain J.C., Lynch T.J., Giovannucci E., Su L., Christiani D.C. Circulating 25-hydroxyvitamin D levels predict survival in early-stage non-small-cell lung cancer patients. J. Clin. Oncol. 2007, 25:479-485.